Jump to Content

< back

Formulating protein based biopharmaceuticals: Controlling aggregation and adsorption

Research Area: Biopharmaceuticals

Supervisors: Prof Clive Prestidge, Dr Benjamin Thierry, Dr Kristen Bremmell (School of Pharmacy) and Dr Tim Barnes (School of Pharmacy)

Description: How does the formulation of biopharmaceuticals control their aggregation and adsorption? Biopharmaceuticals are an important class of therapeutic drugs. Their structure is highly sensitive to the local environment, where denaturing, aggregation and adsorption to container walls may occur. As even minor structural changes can alter protein functionality, biopharmaceutical product formulation is critical to maintain the native protein structure and functionality. Additionally, such sensitivity has severe implications on quality control in manufacturing and purification processes inducing undesirable effects.

 The impact of different aspects of solution formulation on protein aggregation behaviour and their interaction with surfaces will be studied in this project for application in bio-pharmaceutical purification and their use in drug delivery. The follow experimental techniques will be considered for use: Quartz crystal microbalance, isothermal calorimetry, atomic force microscopy, circular dichroism, dynamic light scattering and zeta potential.

top^